Request that the FDA take the following three actions described below: 1Initiate proceedings to reclassify aging from a natural process to a disease for the purposes of regulation and research. 2) Review and consider the scientific and medical evidence presented in support of this reclassification. 3) Amend relevant FDA policies and regulations to reflect the reclassification of aging as a disease